GlassScriptPhysician profile
Emmanuela Wolloch
NPI 1619016391
$926.89
in general payments reported to CMS, 2019-2025
14 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $43.10 · 2022: $289 · 2023: $125 · 2024: $69.42 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.45 |
| Education | $161.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $244.16 | 2022 | |
| Novo Nordisk INC | $161.35 | 2025 | Wegovy |
| Amgen INC. | $124.99 | 2019 | |
| Amag Pharmaceuticals, INC. | $99.20 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $67.04 | 2023 | Adthyza |
| Exact Sciences Corporation | $33.78 | 2025 | The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $29.48 | 2024 | Veozah |
| Shield Therapeutics INC | $29.20 | 2023 | Accrufer |
| Mayne Pharma Commercial LLC | $29.01 | 2023 | |
| Hologic Sales and Service, LLC | $24.32 | 2022 | |
| Allergan, INC. | $24.13 | 2019 | |
| Evofem Biosciences, INC. | $20.95 | 2024 | |
| Ibsa Pharma INC. | $20.29 | 2022 | |
| Lilly USA, LLC | $18.99 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuela Wolloch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.